Abstract
Induction of differentiation sensitizes chronic myeloid leukemia (CML) cells to the BCR-ABL inhibitor imatinib by mechanisms that remain unknown. We p......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
